Literature DB >> 34280120

Exploring Changes to the Actionability of COVID-19 Dashboards Over the Course of 2020: Descriptive Assessment and Expert Appraisal in the Canadian Context.

Erica Barbazza1, Damir Ivanković1, Sophie Wang2,3, Kendall Jamieson Gilmore4, Mircha Poldrugovac1, Claire Willmington4, Nicolas Larrain2,3, Véronique Bos1, Sara Allin5, Niek Klazinga1, Dionne Kringos1.   

Abstract

BACKGROUND: Public, web-based COVID-19 dashboards are in use worldwide to communicate pandemic-related information. Actionability of dashboards-as a predictor of their potential use for data-driven decision-making-was assessed in a global study during the early stages of the pandemic. It revealed a widespread lack of features needed to support actionability. In view of the inherently dynamic nature of dashboards and their unprecedented speed of creation, the evolution of the dashboards and changes to their actionability merits exploration.
OBJECTIVE: To explore how COVID-19 dashboards evolved in the Canadian context during 2020 and whether the presence of actionability features changed over time.
METHODS: We conducted a descriptive assessment of a pan-Canadian sample of COVID-19 dashboards (N=26), followed by an appraisal of changes to their actionability by a panel of expert scorers (N=8). Scorers assessed the dashboards at two points in time, July and November 2020, using an assessment tool informed by communication theory and health care performance intelligence. Applying the nominal group technique, scorers were grouped in panels of three, and evaluated the presence of the seven defined features of highly actionable dashboards at each time point.
RESULTS: Improvements had been made to the dashboards over time. These predominantly involved data provision (specificity of geographic breakdowns, range of indicators reported, explanations of data sources or calculations) and advancements enabled by the technologies employed (customization of time trends, interactive or visual chart elements). Further improvements in actionability were noted especially in features involving local-level data provision, time-trend reporting, and indicator management. No improvements were found in communicative elements (clarity of purpose and audience), while the use of storytelling techniques to narrate trends remained largely absent from the dashboards.
CONCLUSIONS: Improvements to COVID-19 dashboards in the Canadian context during 2020 were seen mostly in data availability and dashboard technology. Further improving the actionability of dashboards for public reporting will require attention to both technical and organizational aspects of dashboard development. Such efforts would include better skill-mixing across disciplines, continued investment in data standards, and clearer mandates for their developers to ensure accountability and the development of purpose-driven dashboards.

Entities:  

Year:  2021        PMID: 34280120     DOI: 10.2196/30200

Source DB:  PubMed          Journal:  J Med Internet Res        ISSN: 1438-8871            Impact factor:   5.428


  2 in total

1.  The experiences of 33 national COVID-19 dashboard teams during the first year of the pandemic in the World Health Organization European Region: A qualitative study.

Authors:  Erica Barbazza; Damir Ivanković; Karapet Davtyan; Mircha Poldrugovac; Zhamin Yelgezekova; Claire Willmington; Bernardo Meza-Torres; Véronique L L C Bos; Óscar Brito Fernandes; Alexandru Rotar; Sabina Nuti; Milena Vainieri; Fabrizio Carinci; Natasha Azzopardi-Muscat; Oliver Groene; David Novillo-Ortiz; Niek Klazinga; Dionne Kringos
Journal:  Digit Health       Date:  2022-08-29

2.  Report from the Ready for the Next Round Thought-Leadership Roundtables on Building Resilience in Cancer Care and Control in Canada-Colorectal Cancer Canada; 2021.

Authors:  Eliya Farah; Maria El Bizri; Radmila Day; Lavina Matai; Fred Horne; Timothy P Hanna; David Armstrong; Susan Marlin; Olivier Jérôme; Darren R Brenner; Winson Cheung; Laszlo Radvanyi; Eva Villalba; Natalie Leon; Chana Cohen; Karine Chalifour; Ronald Burkes; Sharlene Gill; Scott Berry; Brandon S Sheffield; Pamela Fralick; Barry D Stein
Journal:  Curr Oncol       Date:  2022-03-07       Impact factor: 3.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.